• Contraception:
    • Insert 1 implant subdermally
    • Used up to 3 years

Implant: 68mg

  • When an implant is broken or bent, in situ, the release rate of etonogestrel may be slightly increased
  • It is important to remove in its entirety

Progestin

It inhibits pituitary gonadotropin release, inhibiting ovulation. It also alters cervical mucus and endometrium

  • Headache
  • Vaginitis
  • Weight gain
  • Acne
  • Breast pain & tenderness
  • Menstrual irregularities
  • Breakthrough bleeding
  • Amenorrhea
  • Abdominal pain
  • Pharyngitis
  • Leukorrhea
  • Implant site reaction
  • Influenza-like symptoms
  • Dizziness
  • Dysmenorrhea
  • Back pain
  • Emotional lability
  • Nausea
  • Pain
  • Nervousness
  • Depression
  • Hypersensitivity reaction
  • Vision changes
  • Contact lens intolerance
  • Glucose intolerance
  • Fluid retention
  • Elevated BP
  • Increased cholesterol
  • Hypersensitivity to class/components
  • Pregnancy
  • <21 days postpartum (non-breastfeeding patients)
  • <4 week postpartum (breastfeeding patients)
  • Undiagnosed vaginal bleeding
  • Thromboembolism or history
  • Breast cancer or history
  • Progestin-dependent cancer or history
  • Benign or malignant hepatic tumor
  • Active hepatic disease
  • Fosamprenavir
  • Tranexamic acid

                          Drug Status

Availability Prescription only
Pregnancy Not indicated
Breastfeeding Avoid use if <4 week postpartum
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Implanon NXT 68mg Implant 1’s N. V. Organon Imperial Managed